Colts Notebook: Nelson's impact remains eliteMineralys Therapeutics (NASDAQ:MLYS) Trading Down 4.1% – What’s Next?
Vanguard Total Stock Market ETF (NYSEARCA:VTI) Sees Strong Trading Volume – What’s Next?
New Canadians, non-traditional demographics boost minor hockey uptake in B.C.Better late than never, the Browns’ offensive line is showing it no longer is the discombobulated bunch it appeared to be in the first seven games. It is no coincidence that the improved blocking from the line began when right tackle Jack Conklin returned from a serious knee injury suffered in the season opener last year followed by a hamstring injury suffered in practice this season just as he was ready to return from the knee injury. Jameis Winston was sacked only once Nov. 21 when the Browns beat the Steelers, 24-19. Coach Kevin Stefanski did not call out the [...]
Evolus, Inc. ( NASDAQ:EOLS – Get Free Report ) insider Rui Avelar sold 2,252 shares of the firm’s stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $10.85, for a total value of $24,434.20. Following the sale, the insider now directly owns 366,595 shares of the company’s stock, valued at approximately $3,977,555.75. This trade represents a 0.61 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link . Evolus Stock Down 2.3 % Shares of NASDAQ EOLS opened at $11.09 on Friday. The business has a 50-day moving average of $13.46 and a two-hundred day moving average of $13.73. The company has a market capitalization of $702.23 million, a price-to-earnings ratio of -12.19 and a beta of 1.27. Evolus, Inc. has a 1 year low of $9.80 and a 1 year high of $17.82. The company has a debt-to-equity ratio of 20.58, a current ratio of 2.47 and a quick ratio of 2.23. Wall Street Analysts Forecast Growth Several research analysts have recently commented on EOLS shares. Barclays raised their price target on Evolus from $16.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday, September 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $22.00 target price on shares of Evolus in a research report on Friday, September 13th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Evolus in a research note on Monday, September 16th. Finally, HC Wainwright reissued a “buy” rating and issued a $27.00 price objective on shares of Evolus in a research note on Thursday, November 7th. Hedge Funds Weigh In On Evolus A number of institutional investors and hedge funds have recently added to or reduced their stakes in EOLS. Quest Partners LLC purchased a new stake in shares of Evolus during the 2nd quarter worth approximately $43,000. Quarry LP acquired a new stake in Evolus during the 2nd quarter worth $54,000. Point72 Asset Management L.P. purchased a new stake in Evolus in the third quarter valued at $132,000. Dynamic Technology Lab Private Ltd acquired a new position in Evolus in the third quarter valued at $191,000. Finally, Profund Advisors LLC purchased a new position in shares of Evolus during the second quarter worth about $130,000. 90.69% of the stock is owned by institutional investors and hedge funds. About Evolus ( Get Free Report ) Evolus, Inc, a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. Further Reading Receive News & Ratings for Evolus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolus and related companies with MarketBeat.com's FREE daily email newsletter .
Jimmy Carter: Former US President dies aged 100Colts Notebook: Nelson's impact remains eliteClinical and regulatory success in 2024 expected to drive value in 2025 CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "In fiscal year 2024 we drove tremendous progress in our pipeline. It was a transformative year, marked by our first FDA approval and significant clinical milestones. The approval of LYMPHIRTM and the positive Phase 3 results for Mino-Lok® underscore our commitment to developing innovative therapies. Our team successfully responded to FDA comments related to the biologics license application for LYMPHIR and ultimately gained FDA approval. Productive engagement with the FDA regarding the positive results of our Phase 3 Mino-Lok® trial and Phase 2 Halo-Lido trial clarified our next steps for both programs. We anticipate continued engagement with the agency in the coming year and look forward to their guidance. Additionally, we are exploring strategic partnerships and licensing opportunities to maximize the potential of our portfolio and bring these important therapies to market efficiently," stated Leonard Mazur , Chairman and CEO of Citius Pharma. "Looking ahead, our priorities for fiscal year 2025 include launching LYMPHIRTM through our majority-owned subsidiary, Citius Oncology, driving the clinical and regulatory strategies for Mino-Lok® and Halo-Lido, fortifying our financial position, and applying a disciplined approach to resource allocation. We expect to launch LYMPHIR in the first half of 2025 and distribute CTOR shares to Citius Pharma shareholders by the end of the year, pending favorable market conditions. Our goal remains to deliver value for patients, healthcare providers, and shareholders. With a clear vision and a strong team, we are well-positioned to execute on our mission of bringing innovative therapies to market," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Liquidity As of September 30, 2024 , the Company had $3.3 million in cash and cash equivalents. As of September 30, 2024 , the Company had 7,247,243 common shares outstanding, as adjusted for the 1-for-25 reverse stock split of the Company's common stock, effected on November 25, 2024 . During the year ended September 30, 2024 , the Company received net proceeds of $13.8 million from the issuance of equity. The Company expects to raise additional capital to support operations. Research and Development (R&D) Expenses R&D expenses were $11.9 million for the full year ended September 30, 2024 , compared to $14.8 million for the full year ended September 30, 2023 . The decrease in R&D expenses primarily reflects the completion of the Halo-Lido trial and completion of activities related to the regulatory resubmission for LYMPHIR, offset by shutdown costs associated with the end of the Phase 3 trial for Mino-Lok. We expect research and development expenses to decrease in fiscal year 2025 as we continue to focus on the commercialization of LYMPHIR through our majority-owned subsidiary, Citius Oncology and because we have completed the Phase 3 trial for Mino-Lok. General and Administrative (G&A) Expenses G&A expenses were $18.2 million for the full year ended September 30, 2024 , compared to $15.3 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-launch and market research activities associated with LYMPHIR. General and administrative expenses consist primarily of compensation costs, professional fees for legal, regulatory, accounting and corporate development services, and investor relations expenses. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $11.8 million as compared to $6.6 million for the prior year. The increase of $5.2 million is largely due to the grant of options under the Citius Oncology stock plan. Stock-based compensation expense under the Citius Oncology stock plan was $7.5 million during the year ended September 30, 2024 , compared to $2.0 million for the year ended September 30, 2023 , as the plan was initiated in July 2023 . For the years ended September 30, 2024 and 2023, stock-based compensation expense also includes $47,547 and $130,382 , respectively, for the NoveCite stock option plan. In fiscal years 2023 and 2024, we granted options to our new employees and additional options to other employees, our directors, and consultants. Net loss Net loss was $39.4 million , or ($5.97) per share for the year ended September 30, 2024 , compared to a net loss of $32.5 million , or ($5.57) per share for the year ended September 30, 2023 , as adjusted for the reverse stock split. The increase in net loss reflects an increase in operating expense of $5.3 million offset by a decrease of $1.6 million in other income. Operating expense increased due to increases in stock-based compensation and general and administrative expenses, which were offset by decreased research and development expense. About Citius Pharmaceuticals, Inc. Citius Pharma is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. In August 2024 , the FDA approved LYMPHIRTM, a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Citius Pharma's late-stage pipeline also includes Mino-Lok®, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 Trial. Citius Pharma is actively engaged with the FDA to outline next steps for both programs. For more information, please visit www.citiuspharma.com . Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Pharma. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Pharma are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR through our majority-owned subisity and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; risks related to research using our assets but conducted by third parties; risks relating to the results of research and development activities, including those from our existing and any new pipeline assets; our ability to maintain compliance with Nasdaq's continued listing standards; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; the early stage of products under development; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Pharma's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS PHARMACEUTICALS, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 ASSETS Current Assets: Cash and cash equivalents $ 3,251,880 $ 26,480,928 Inventory 8,268,766 — Prepaid expenses 2,700,000 7,889,506 Total Current Assets 14,220,646 34,370,434 Property and equipment, net — 1,432 Operating lease right-of-use asset, net 246,247 454,426 Other Assets: Deposits 38,062 38,062 In-process research and development 92,800,000 59,400,000 Goodwill 9,346,796 9,346,796 Total Other Assets 102,184,858 68,784,858 Total Assets $ 116,651,751 $ 103,611,150 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 4,927,211 $ 2,927,334 License payable 28,400,000 — Accrued expenses 17,027 476,300 Accrued compensation 2,229,018 2,156,983 Operating lease liability 241,547 218,380 Total Current Liabilities 35,814,803 5,778,997 Deferred tax liability 6,713,800 6,137,800 Operating lease liability – non current 21,318 262,865 Total Liabilities 42,549,921 12,179,662 Commitments and Contingencies Stockholders' Equity: Preferred stock - $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding — — Common stock - $0.001 par value; 16,000,000 shares authorized; 7,247,243 and 6,354,371 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,247 6,354 Additional paid-in capital 271,440,421 253,056,133 Accumulated deficit (201,370,218) (162,231,379) Total Citius Pharmaceuticals, Inc. Stockholders' Equity 70,077,450 90,831,108 Non-controlling interest 4,024,380 600,380 Total Equity 74,101,830 91,431,488 Total Liabilities and Equity $ 116,651,751 $ 103,611,150 Reflects a 1-for-25 reverse stock split effective November 25, 2024. CITIUS PHARMACEUTICALS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 11,906,601 14,819,729 General and administrative 18,249,402 15,295,584 Stock-based compensation – general and administrative 11,839,678 6,616,705 Total Operating Expenses 41,995,681 36,732,018 Operating Loss (41,995,681) (36,732,018) Other Income: Interest income, net 758,000 1,179,417 Gain on sale of New Jersey net operating losses 2,387,842 3,585,689 Total Other Income Net 3,145,842 4,765,106 Loss before Income Taxes (38,849,839) (31,966,912) Income tax expense 576,000 576,000 Net Loss (39,425,839) (32,542,912) Net loss attributable to non-controlling interest 287,000 - Deemed dividend on warrant extension (1,047,312) (1,151,208) Net Loss Applicable to Common Stockholders $ (40,186,151) (33,694,120) Net Loss Per Share Applicable to Common Stockholders - Basic and Diluted $ (5.97) (5.57) Weighted Average Common Shares Outstanding
The transition to lower-carbon energy will require a massive investment. According to Goldman Sachs , the world needs to invest an estimated $3 trillion annually through the end of the decade to support its goals of reaching net zero carbon emissions in the coming decades. That massive investment spans multiple opportunities, including renewable energy, electricity grids, and increased electrification. One company that is absolutely critical to building this infrastructure is Quanta Services ( PWR -2.26% ) . It's the industry leader in providing specialized infrastructure solutions. Here's a closer look at this crucial infrastructure stock . Digging into Quanta Services Quanta Services provides specialized infrastructure solutions to the utilities , renewable energy , technology, communications, pipeline , and energy industries. Its client list is a who's who of industry leaders in those respective sectors, including Duke Energy , NextEra Energy ( NEE -0.36% ) , Verizon , and Enbridge . It helps these companies design, install, repair, and maintain their infrastructures. While the company's services span several infrastructure assets, about three-quarters of its revenues come from utilities and renewable energy developers. That puts it in a strong position to capitalize on the growing total addressable market opportunity for infrastructure related to the transition to lower-carbon energy. For example, investor-owned U.S. electric utilities (e.g., Duke Energy and NextEra) expect to incur $186.4 billion in capital expenses to maintain and expand their electricity transmission and distribution systems and power-generating capabilities this year. They will spend $51 billion on power-generation projects, with 65% of that capital going toward renewable energy. That number should rise significantly in the coming years. Forecasters estimate that the U.S. will deploy 375-450 gigawatts (GW) of new renewable and storage capacity over the next seven years. That's three times more capacity than the country deployed over the last seven (140 GW). Customers like NextEra Energy are driving this acceleration (it expects to more than double its renewables and storage capacity from 38 GW today to 81 GW by 2027). NextEra Energy is also investing capital to build out transmission lines and maintain and expand its electric utility operations in Florida. That's just one opportunity in one country. Quanta Services operates across multiple industries and countries, providing customers with a growing array of services . The strong performance should continue Increasing infrastructure investment is driving strong growth for Quanta Services this year. It delivered another quarter of double-digit growth in the third quarter. Its revenue rose from $5.6 billion to $6.5 billion, while its adjusted earnings increased from $2.24 per share to $2.72. It also generated $539.5 million in cash flow, pushing its year-to-date total to nearly $1.4 billion (with almost $980 million in free cash). That strong performance has helped drive a more than 50% increase in its stock price this year. Quanta Services is in a strong position to continue growing. It ended the third quarter with a record $34 billion of projects in its backlog. That gives it a lot of confidence in its continued growth. "We believe we are well positioned to achieve another year of double-digit earnings-per-share growth in 2025 due to increasing demand for our services, strong execution of our strategic plan and capital deployment opportunities," stated CEO Duke Austin in the third-quarter earnings press release. The company has been enhancing its ability to continue growing and capture a greater share of the massive opportunity it sees ahead for energy transition investments. Quanta has made several acquisitions and investments over the past year to bolster its capabilities, including acquiring Cupertino Electric (a premier electrical infrastructure solution provider) and investing in Hybar (a company building a technologically advanced scrap metal recycling rebar mill ). It has also invested capital back into its business to drive additional organic growth. The company believes these investments will enable it to deliver solid revenue and earnings growth over the long term. A potentially compelling way to invest in this massive megatrend The world will invest trillions of dollars in building lower-carbon energy infrastructure in the coming years. That trend plays right into the strengths of Quanta Services, which is a leading provider of specialized infrastructure solutions to utilities and renewable energy developers. It should drive continued healthy growth for the company, making it a potentially compelling way to invest in this massive megatrend.
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Zeta Global Holdings Corp. (NYSE: ZETA) securities between February 27, 2024 and November 13, 2024. Zeta is a marketing technology company. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Zeta Global Holdings Corp. (ZETA) Failed to Disclose it was Artificially Inflating Financial Results According to the complaint, on November 13, 2024, market research group Culper Research published a report entitled "Zeta Global Holdings Corp (ZETA): Shams, Scams, and Spam.” The report alleged that the “integrity of the Company’s data collection and reported financials” is severely undermined by two factors. First, the report alleged that “Zeta has formed ‘two-way’ contracts with third party consent farms wherein the Company simultaneously acts as both a supplier and a buyer of consumer data,” allowing the Company to “flatter reported revenue growth” and indicating possible “round-tripping” of revenue. Second, the report alleged that Zeta’s collects the majority of its customer data from a network of “sham websites that hoodwink millions of consumers each month into handing their data over to Zeta under false pretenses.” For example, the report alleged the Company and its subsidiaries operate a number of fake job boards which are designed to trick individuals into submitting personal data under the pretense of job applications. The report further alleged that the Company’s “most valuable data” comes from these predatory websites, dubbed consent farms, which are “responsible for almost the entirety of the Company’s growth.” On this news, the Company’s stock price fell $10.46, or 37.07%, to close at $17.76 per share on November 13, 2024. Plaintiff alleges that during the class period, defendants failed to disclose that: (1) Zeta used two-way contracts to artificially inflate financial results; (2) Zeta engaged in round trip transactions to artificially inflate financial results; (3) Zeta utilized predatory consent farms to collect user data; and (4) that these consent farms have driven almost the entirety of Zeta’s growth. What Now : You may be eligible to participate in the class action against Zeta Global Holdings Corp. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by January 21, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP : Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Zeta Global Holdings Corp. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a9e62a12-06db-424e-a9a1-12ca4ed447d5
Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business UpdateDecember 29 - The Los Angeles Lakers traded guard D'Angelo Russell, forward Maxwell Lewis and three second-round draft picks to the Brooklyn Nets on Sunday in exchange for forward Dorian Finney-Smith and guard Shake Milton. The Lakers will send their second-round picks in 2027, 2030 and 2031 to Brooklyn in the deal, ESPN reported. It marks the second time that Russell, 28, has been dealt from the Lakers to the Nets. Los Angeles selected him No. 2 overall in the 2015 NBA Draft, and he spent two seasons there before being traded on June 22, 2017, with Timofey Mozgov to the Nets for Brook Lopez and draft pick Kyle Kuzma. Russell made stops with the Golden State Warriors and Minnesota Timberwolves before the Lakers acquired him again on Feb. 9, 2023, as part of a three-team deal. Russell's role in head coach J.J. Redick's rotation had diminished. In October, Russell averaged 30.6 minutes per game, dropping to 25.5 in November and 25.2 in December. n 29 games (10 starts) this season, he's averaging 26.3 minutes, 12.4 points, 2.8 rebounds and 4.7 assists. All are below his career averages of 30 minutes, 17.5 points, 3.4 rebounds and 5.7 assists. Lewis, 22, has seen limited action for the Lakers this season, with the small forward scoring 15 points in seven games. Finney-Smith, 31, is in his ninth NBA season. He has started all 20 games he's appeared in, averaging 10.4 points, 4.6 rebounds and 1.6 assists over 29 minutes per game. ilton, 28, is averaging 7.4 points per game over 27 appearances (one start). He is also contributing 1.9 rebounds and 2.4 assists. --Field Level Media Our Standards: The Thomson Reuters Trust Principles. , opens new tab
Cleveland-Cliffs Inc. ( NYSE:CLF – Get Free Report ) shares fell 2.6% during trading on Thursday . The company traded as low as $9.15 and last traded at $9.21. 1,808,144 shares changed hands during mid-day trading, a decline of 83% from the average session volume of 10,768,788 shares. The stock had previously closed at $9.46. Wall Street Analyst Weigh In Several equities research analysts have issued reports on the stock. StockNews.com downgraded shares of Cleveland-Cliffs from a “hold” rating to a “sell” rating in a research report on Thursday, November 7th. The Goldman Sachs Group began coverage on Cleveland-Cliffs in a report on Monday, December 2nd. They set a “buy” rating and a $16.00 price target for the company. Citigroup decreased their price objective on Cleveland-Cliffs from $12.50 to $11.00 and set a “neutral” rating on the stock in a report on Thursday, December 19th. Finally, Morgan Stanley dropped their target price on Cleveland-Cliffs from $15.00 to $13.50 and set an “equal weight” rating for the company in a report on Wednesday, September 18th. Three analysts have rated the stock with a sell rating, five have issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Cleveland-Cliffs has an average rating of “Hold” and a consensus price target of $17.22. Check Out Our Latest Stock Analysis on Cleveland-Cliffs Cleveland-Cliffs Trading Down 1.2 % Cleveland-Cliffs ( NYSE:CLF – Get Free Report ) last announced its quarterly earnings data on Monday, November 4th. The mining company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.02). Cleveland-Cliffs had a negative net margin of 2.31% and a negative return on equity of 0.59%. The firm had revenue of $4.57 billion during the quarter, compared to the consensus estimate of $4.72 billion. During the same period last year, the business earned $0.54 earnings per share. The business’s revenue was down 18.5% compared to the same quarter last year. As a group, equities research analysts forecast that Cleveland-Cliffs Inc. will post -0.45 EPS for the current fiscal year. Institutional Trading of Cleveland-Cliffs Several institutional investors and hedge funds have recently modified their holdings of CLF. Franklin Resources Inc. raised its stake in Cleveland-Cliffs by 105.6% during the third quarter. Franklin Resources Inc. now owns 262,771 shares of the mining company’s stock worth $3,429,000 after acquiring an additional 134,939 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Cleveland-Cliffs during the 3rd quarter worth approximately $64,000. Arete Wealth Advisors LLC bought a new position in Cleveland-Cliffs in the 3rd quarter valued at approximately $1,222,000. Neo Ivy Capital Management acquired a new stake in Cleveland-Cliffs in the third quarter valued at approximately $1,444,000. Finally, First Dallas Securities Inc. grew its stake in shares of Cleveland-Cliffs by 27.9% during the third quarter. First Dallas Securities Inc. now owns 206,750 shares of the mining company’s stock worth $2,640,000 after buying an additional 45,150 shares during the last quarter. 67.68% of the stock is currently owned by institutional investors. Cleveland-Cliffs Company Profile ( Get Free Report ) Cleveland-Cliffs is the largest flat-rolled steel company and the largest iron ore pellet producer in North America. The company is vertically integrated from mining through iron making, steelmaking, rolling, finishing and downstream with hot and cold stamping of steel parts and components. The company was formerly known as Cliffs Natural Resources Inc and changed its name to Cleveland-Cliffs Inc in August 2017. See Also Receive News & Ratings for Cleveland-Cliffs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cleveland-Cliffs and related companies with MarketBeat.com's FREE daily email newsletter .TCL to Reveal its QD-Mini LED tech at CES 2025Donald Trump asked the Supreme Court to pause a law that would ban TikTok. The president-elect filed a brief urging SCOTUS to give him time to pursue a political resolution. Congress passed a law that requires TikTok's Chinese owners to divest or be banned from US app stores. President-elect Donald Trump asked the Supreme Court to pause the law that would ban TikTok in mid-January until after his inauguration. Trump filed a brief on Friday urging the top court to give him time to "pursue a political resolution" before agreeing to ban the social media app. In April, Congress passed a bipartisan law that established a nine-month deadline for TikTok's Chinese parent company to divest from the app or be barred from US app stores. Neither TikTok nor Trump's lawyers immediately responded to Business Insider's request for comment. BI also reached out to the Supreme Court. In the Friday filing, Trump's lawyers highlighted the president-elect's "consummate deal-making expertise," suggesting Trump has the "political will" to negotiate a resolution that would simultaneously "save the platform" and address the national security concerns highlighted in the Congressional bill. The nine-month deadline is officially up on January 19, which is one day before Trump assumes office for a second time. Trump previously supported a TikTok ban but appeared to change his mind in recent months. He met with the app's CEO earlier this month and said he had a "warm spot" in his heart for TikTok. Legal experts previously told BI that Trump has a couple of options to try to keep the app running in the US, including asking his Department of Justice to ignore the divest law or trying to rework strategic interpretations of the law. Trump and his lawyers also argue that the president-elect has a mandate from American voters to protect their free-speech rights, including those who use TikTok. "Moreover, President Trump is one of the most powerful, prolific, and influential users of social media in history," the file said." "Consistent with his commanding presence in this area, President Trump currently has 14.7 million followers on TikTok with whom he actively communicates, allowing him to evaluate TikTok's importance as a unique medium for freedom of expression, including core political speech," lawyers added.
Chennai, Dec 28 (PTI) Amidst severe criticism from various political parties over his whiplash agitation, Tamil Nadu BJP chief K Annamalai on Saturday said his action should be likened to that of a "brother's primal anger" over the sexual assault of his sister. His action should not be viewed as political but ought to be seen as an elder brother's outburst over the "system failure" in the state, Annamalai said a day after he staged a unique whiplash agitation of flogging himself to condemn the ruling DMK and the state police over the handling of the case of sexual assault on a Chennai college student. "Don't see me as a political party leader but see me as the affected girl's elder brother. It's (inflicting whiplash on himself) like primal anger of a brother because the system has failed," Annamalai told reporters at the airport here when sought for his reaction. "Has the police been impartial in handling the case? No. There was no chance for the FIR to get leaked. How did it get leaked?" the BJP president asked. He lashed himself several times with a whip in front of his house in Coimbatore demanding justice for the Anna University student who was sexually assaulted on Christmas Eve. The police had arrested the suspect in the case. Several political parties including the ruling DMK had mocked Annamalai for the agitation which was also to dislodge the DMK government. He had vowed not to wear sandals till the DMK was dethroned and had even begun a 48-day ritual for a pilgrimage to Murugan temples. Also, he justified his stance on the issue. He said the "system has deteriorated" in the state. Former Governor Dr Tamilisai Soundararajan and BJP members were arrested when they staged a protest demanding justice for the affected girl student. "So I was constrained to take up this agitation. I have taken up the issue with a religious zeal," Annamalai said. (This story has not been edited by THE WEEK and is auto-generated from PTI)
Native American patients are sent to collections for debts the government owesFORMER Mandaue City mayor Jonas Cortes is set to file a motion for reconsideration (MR) with the Supreme Court (SC) on Thursday, Jan. 2, 2025, as his final attempt to overturn the cancellation of his certificate of candidacy (COC) and his disqualification from the May 2025 National and Local Elections. The Commission on Elections (Comelec) en banc denied Cortes’ appeal on Friday, December 27, upholding an earlier decision by the Comelec Second Division to cancel his COC due to alleged material misrepresentation in his candidacy documents. Cortes announced his plan to elevate the case to the SC in a statement released on Friday, expressing optimism that the country’s highest judicial body would render a fair decision. “We have done everything within the Comelec process and will now seek justice from the Supreme Court,” he said in Cebuano. “This is not the end of our cause for justice; instead, it marks the beginning of our fight for truth and fairness.” The prayer for the SC in the MR is to recognize and acknowledge the urgency of the request for a temporary restraining order (TRO) or any other remedy being sought, so it can be immediately addressed in one of their en banc sessions. The remedy requires a real sense of urgency and cannot afford any delays, said City Administrator Jamaal James Calipayan in a previous interview. The controversy stems from Cortes’ response to a question in his COC, wherein he marked “N/A” to whether he had been found liable for a crime with an accessory penalty of perpetual disqualification that had become final and executory. The Comelec Second Division initially ruled that Cortes’ answer constituted material misrepresentation, as it omitted crucial details about a pending case and a previous dismissal from service. On Dec. 23, Cortes filed an MR with the Comelec en banc, seeking to reverse the decision. However, the en banc affirmed the Second Division’s findings. In its decision penned by Comelec Chairman George Erwin Garcia and six commissioners — Marlon Casquejo, Rey Bulay, Nelson Celis, Ernesto Ferdinand Maceda Jr., Aimee Ferolino and Socorro Inting — the Comelec ruled that Cortes’ omission was deliberate and material to his eligibility. “We find no cogent reason to depart from the Assailed Resolution of the Commission (Second Division),” the en banc decision read. “Wherefore, premises considered, the Commission (En Banc) resolved, as it hereby resolves, to deny the Motion for Reconsideration. The Assailed Resolution is hereby affirmed,” the decision added. The ruling cited Section 78 in relation to Section 74 of the Omnibus Election Code (OEC), which mandates that facts stated in a COC must be true. Any false representation of a material fact serves as a basis for the cancellation of the certificate. Calipayan defended Cortes’ COC response, asserting that it was accurate at the time of filing. “When we filled that out, we even consulted Comelec, and they confirmed that the answer should be ‘no’ because there was no final and executory ruling,” Calipayan said. Cortes’ legal team also argued that the Comelec rulings failed to acknowledge the lack of a final judgment against Cortes at the time of his candidacy filing. The team plans to request a TRO or a status quo ante order from the SC to allow Cortes to continue his campaign while the case is under judicial review. The team has maintained that the Comelec’s interpretation of Cortes’ candidacy documents was unjust and inconsistent with due process. Cortes remains steadfast in his belief that the SC will overturn the Comelec ruling, emphasizing his commitment to serving the people of Mandaue City. “Ang uwahing desisyon sa Comelec naghagit kanato sa pagpangita sa kaangayan ug katarungan (Comelec’s recent decision challenges us to seek fairness and justice),” Cortes said. Calipayan said Cortes’ legal team is preparing legal arguments and holding onto hope that justice will ultimately prevail. The issue stems from an Oct. 25 petition filed by lawyer Ervin Estandarte, alleging material misrepresentation in Cortes’ COC. Despite the Comelec en banc affirming its earlier ruling to cancel his COC and disqualify him from running, Cortes has assured his supporters that he will fight back for justice. One of Cortes’ staunch supporters is Regal Oliva, who is running for a congressional seat and is part of Cortes’ political team. Oliva released a statement backing Cortes’ move to seek a SC reversal. “The Comelec en banc’s decision to affirm the Second Division’s ruling, and deny Mayor Jonas Cortes’ motion for reconsideration raises serious concerns.” Oliva added, “This could lead to Mayor Jonas Cortes being excluded from the May 2025 ballots, potentially disenfranchising the people of Mandaue City.” She emphasized the importance of the SC’s role in ensuring democratic fairness: “May they render a decision that upholds justice, fairness, and the people’s democratic right to elect their chosen leader.” /CAVMONTREAL — A childhood friend of the Quebec man killed in a Florida boat explosion Monday said one of the victim's sisters was among the other six passengers injured in the blast. Thi Cam Nhung Lê said 41-year-old Sebastien Gauthier was celebrating the holidays with his family when the explosion occurred in Fort Lauderdale. Lê said Gauthier’s older sister was also on the boat when it erupted into flames, and she was taken to a hospital. “It’s unimaginable, incomprehensible,” Lê said Saturday, adding that Gauthier’s family and mutual friends informed her about his death. Lê, 40, said she first met Gauthier in her early adolescence and they grew up together in Quebec City. She remembers him as a globetrotter who always had a smile on his face. “He’s still my best friend. It’s always him I call if I need something, but he’s no longer with us,” she said. The last time the two friends saw each other face-to-face was about two years ago, Lê said, but she last messaged Gauthier on social media in the days before Monday's explosion. And on Jan. 1, her birthday, she would have expected a call from him, just like every year. “I’m shocked, surprised, and feeling a little bit of regret," she said. "You regret not having seen him more. I spent yesterday crying. You can’t believe your friend disappears from one day to the next." Earlier this week, the Florida Fish and Wildlife Conservation Commission confirmed that Gauthier died of his injuries in Broward County. The FWC said its preliminary investigation in Fort Lauderdale showed a 37-foot vessel exploded after its engines were started, injuring all seven passengers on board. Video posted on social media Monday showed the vessel engulfed in flames, with a thick column of black smoke billowing into the sky. However, Florida authorities have not provided The Canadian Press with more information about the investigation. Searching for an explanation has also left Lê angry. As she mourns the loss of her longtime friend, she said she’s still waiting for answers about what led to his unexpected death. This report by The Canadian Press was first published Dec. 28, 2024. Joe Bongiorno, The Canadian Press
Whales with a lot of money to spend have taken a noticeably bearish stance on Amentum Holdings . Looking at options history for Amentum Holdings AMTM we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with bearish. From the overall spotted trades, 2 are puts, for a total amount of $62,908 and 10, calls, for a total amount of $599,620. Predicted Price Range Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $25.0 for Amentum Holdings during the past quarter. Analyzing Volume & Open Interest Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Amentum Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Amentum Holdings's substantial trades, within a strike price spectrum from $20.0 to $25.0 over the preceding 30 days. Amentum Holdings Option Activity Analysis: Last 30 Days Biggest Options Spotted: Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume AMTM CALL SWEEP BULLISH 04/17/25 $2.7 $2.6 $2.7 $25.00 $135.0K 4.9K 2.4K AMTM CALL SWEEP BEARISH 04/17/25 $2.75 $2.65 $2.7 $25.00 $112.8K 4.9K 2.9K AMTM CALL SWEEP BEARISH 04/17/25 $2.5 $2.2 $2.35 $25.00 $58.7K 4.9K 1.6K AMTM CALL SWEEP BEARISH 04/17/25 $2.5 $2.2 $2.35 $25.00 $58.7K 4.9K 1.3K AMTM CALL SWEEP BEARISH 04/17/25 $2.5 $2.35 $2.35 $25.00 $58.7K 4.9K 771 About Amentum Holdings Amentum Holdings Inc is engaged in engineering and technology solutions. The United States and its allies trust it to address their technical and complex scientific, security, and sustainability challenges. Following our analysis of the options activities associated with Amentum Holdings, we pivot to a closer look at the company's own performance. Current Position of Amentum Holdings With a volume of 1,039,781, the price of AMTM is up 1.97% at $20.2. RSI indicators hint that the underlying stock may be approaching oversold. Next earnings are expected to be released in 132 days. Turn $1000 into $1270 in just 20 days? 20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access . Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amentum Holdings with Benzinga Pro for real-time alerts. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
As we draw closer to January, leaks and speculation around Nvidia's next-generation RTX 50-series GPUs are echoing all over the internet. The latest scoop comes from renowned leaker Kopite7kimi providing insights into Nvidia's midrange Blackwell graphics cards, the RTX 5070 Ti and GeForce RTX 5070. As per the leaks, the RTX 5070 Ti is set to feature the GB203-300-A1 GPU, equipped with 8,960 CUDA cores, offering a substantial increase in processing power compared to its predecessor. The card is rumored to include 16GB of GDDR7 VRAM on a 256-bit memory interface, providing enhanced memory bandwidth for demanding applications such as 4K gaming and video editing. Recommended Videos Its total graphics power (TGP) is estimated at 300 watts, indicating high power requirements aligned with its performance capabilities. It is also speculated that the upcoming GPU will be capable of matching the performance of last-gen's RTX 4080. Get... Kunal KhullarExploring the Fundamentals of MCB Electrical Circuit Breakers: Types, Functions, and Applications 12-26-2024 06:54 PM CET | Industry, Real Estate & Construction Press release from: ABNewswire In today's technologically advanced world, ensuring electrical safety is paramount. Miniature Circuit Breakers (MCBs) [ https://www.cncele.com/mcb-terminal-electrical/]play a crucial role in safeguarding electrical systems from potential hazards. These devices are designed to protect electrical circuits from damage caused by overloads and short circuits, making them indispensable in both residential and industrial settings. MCBs not only enhance the safety of electrical installations but also offer reliable and efficient control over electrical distribution. This article delves into the fundamentals of MCBs, highlighting the features, types, and applications of the MCB Terminal Electrical product, and provides insights into the company behind its innovation. Image: https://www.cncele.com/uploads/144.png Understanding MCBs [ https://www.cncele.com/mcb-terminal-electrical/ ] A Miniature Circuit Breaker (MCB) is an automatic electrical switch. It is designed to protect an electrical circuit from damage caused by excess current from an overload or short circuit. Unlike a fuse, which operates once and then needs to be replaced, an MCB can be reset to resume normal operation. This automatic switch is compact and designed for integration in various electrical systems, making it a vital component in modern electrical infrastructure. Basic Functioning of MCB The primary function of an MCB is to interrupt the flow of excessive current to prevent overheating and potential fire hazards. It operates on two key principles: thermal and magnetic trip mechanisms. The thermal mechanism uses a bimetallic strip that bends when heated by excessive current, breaking the circuit. The magnetic mechanism, on the other hand, uses an electromagnet that generates a magnetomotive force to separate the contacts when a sudden surge in current is detected, such as during a short circuit. This dual-action mechanism ensures prompt and efficient disconnection to safeguard electrical appliances and wiring. Importance of Overload and Short Circuit Protection Protection against overloads and short circuits is vital to maintaining electrical safety and operational integrity. Overloads can occur when the electrical demand exceeds the capacity of the circuit, leading to overheating and potential damage to wiring and connected devices. Short circuits, caused by direct contact between live and neutral wires, create a rapid increase in current flow that can result in severe damage and even fire. By providing automatic disconnection, MCBs prevent these dangerous conditions, helping to protect both the electrical system and the property it serves. This proactive measure not only ensures longevity and functionality but also adheres to safety regulations and standards. Product Highlight - MCB Terminal Electrical [ https://www.cncele.com/mcb-terminal-electrical/ ] The MCB Terminal Electrical offered by CNCELE is a state-of-the-art solution engineered to meet modern electrical safety and control needs. Designed with cutting-edge technology, this product stands out for its robustness, reliability, and versatility across various applications. Leveraging advanced materials and meticulous craftsmanship, the MCB Terminal Electrical ensures top-notch performance, making it an indispensable asset in both residential and industrial electrical installations. Key Features1.Overload Protection One of the standout features of the MCB Terminal Electrical is its comprehensive overload protection. By monitoring the current flow and automatically disconnecting the circuit when the load exceeds safe levels, it prevents overheating and potential fire hazards. This feature is crucial for protecting electrical appliances and wiring infrastructure, ensuring longevity and operational safety. 2.Short Circuit Protection Another critical feature is its short circuit protection, which acts instantaneously to cut off the electrical flow in the event of a fault. The MCB Terminal Electrical utilizes an advanced magnetic trip mechanism to detect sudden surges in current, such as those caused by short circuits, providing rapid disconnection to prevent damage to the system and reduce the risk of fire. This quick response is essential for maintaining the integrity of the electrical network and ensuring user safety. 3.Controlling Capability In addition to protection, the MCB Terminal Electrical also offers exceptional controlling capabilities. It can easily be reset after a trip, allowing for quick restoration of normal operation without the need for replacement. This feature not only enhances convenience but also reduces downtime, making it an efficient and user-friendly solution for managing electrical circuits. 4.Versatility in Residential, Non-Residential, Energy Source Industry, and Infrastructure The versatility of the MCB Terminal Electrical is another highlight, making it suitable for a wide range of applications. Whether in residential buildings, non-residential structures, the energy source industry, or broader infrastructure projects, this product proves to be highly adaptable and effective. Its capacity to cater to various requirements without compromising on performance positions it as a versatile choice for diverse electrical installations. Image: https://www.cncele.com/uploads/145.png Image: https://www.cncele.com/uploads/234.png By incorporating these comprehensive features, the MCB Terminal Electrical stands as a superior product, offering advanced protection and control to ensure safety and efficiency in modern electrical systems. Classification of Instantaneous Release Types Miniature Circuit Breakers (MCBs) come in various types, each classified by their instantaneous tripping characteristics. This classification helps in selecting the appropriate MCB based on the nature of the loads and the application requirements. The primary types are Type B, Type C, and Type D, each catering to different scenarios and electrical loads. 1.Type B (3-5)ln Type B MCBs are designed to trip instantaneously when the current flowing through them reaches between 3 to 5 times the rated current (In). These MCBs are highly sensitive to short-circuits and are best suited for applications with low inrush currents. Typical installation environments include residential settings and light commercial use, where the loads predominantly include lighting and small appliances. Their quick response ensures minimal damage in case of a fault, making them ideal for protecting circuits with more delicate equipment. 2.Type C (5-10)ln Type C MCBs trip instantaneously at currents ranging from 5 to 10 times the rated current. These are suitable for environments where moderate inrush currents are common, such as general industrial and commercial applications. They provide a balanced approach between sensitivity to low-level faults and robustness against transient surges caused by equipment like motors, transformers, and fluorescent lighting. Their versatility makes them a popular choice in buildings with mixed load types, offering reliable protection without frequent nuisance tripping. 3.Type D (10-20)ln Type D MCBs are designed to trip instantaneously when the current reaches 10 to 20 times the rated current. These are specifically tailored for environments that experience high inrush currents, typically seen in heavy industrial applications. Loads such as motors, welding equipment, X-ray machines, and large transformers can cause significant surges during startup. The higher tolerance of Type D MCBs ensures that these initial surges do not cause unwanted tripping while still providing prompt disconnection during genuine fault conditions, thus safeguarding heavy-duty equipment and infrastructure. Application Scenarios for Each Type Type B (3-5)ln: Ideal for domestic or light commercial applications with highly sensitive loads, such as household appliances and lighting circuits. These MCBs are best used in environments without significant surges in current, ensuring protection without unnecessary interruptions. Type C (5-10)ln: Suitable for both residential and industrial settings where moderate inrush currents are present. These MCBs find applications in protecting circuits powering motors, transformers, and lighting systems in commercial buildings, workshops, and small manufacturing units. Their balanced approach makes them adaptable for a wide range of uses. Type D (10-20)ln: Best for heavy industrial applications where high inrush currents are a norm. These are typically employed in protection scenarios involving large motors, high-powered machinery, and equipment with substantial startup current requirements. Industrial plants, manufacturing facilities, and environments with heavy-duty electrical equipment benefit the most from Type D MCBs. By understanding the characteristics and application scenarios of these MCB types, it becomes easier to select the right protection device for specific electrical installations, ensuring both safety and operational efficiency. The MCB [ https://www.cncele.com/mcb-terminal-electrical/ ] Terminal Electrical offers a multitude of features designed to deliver reliable and efficient protection for diverse electrical installations. Its versatility allows for seamless integration across residential, non-residential, energy source industry, and broader infrastructure projects. Each type of MCB-Type B, Type C, and Type D-caters to specific application needs, ensuring the right balance between sensitivity to faults and robustness against inrush currents. This specificity in design makes the MCB Terminal Electrical a practical choice for safeguarding various electrical circuits. Media Contact Company Name: CNC ELECTRIC GROUP CO.,LTD. Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=exploring-the-fundamentals-of-mcb-electrical-circuit-breakers-types-functions-and-applications ] Phone: 86-577-61989999 Address:CNC High-Tech Hutou Industrial Zone, Liushi Town City: Yueqing State: Wenzhou Country: China Website: https://www.cncele.com/ This release was published on openPR.